Cooper Companies Bundle
Who Owns The Cooper Companies?
Understanding The Cooper Companies' ownership is key to its strategy and market standing. In September 2023, the company moved its stock listing to Nasdaq, aligning with leading tech and medical firms.
Founded in 1958, The Cooper Companies has evolved significantly, now operating in contact lenses and women's health solutions. Its global reach impacts millions, underscoring its importance in the healthcare sector.
Who owns The Cooper Companies?
The ownership of The Cooper Companies is primarily distributed among institutional investors and public shareholders. As of August 1, 2025, its market capitalization stood at approximately $14.14 billion USD. Major institutional holders include Vanguard Group Inc., BlackRock Inc., and Capital World Investors, collectively holding substantial portions of the company's stock. These large investment firms manage assets on behalf of numerous clients, making them significant stakeholders. Individual investors also own shares, contributing to the company's public float. The company's strategic decisions and financial performance are thus influenced by the collective interests of these diverse ownership groups. For a deeper analysis of its market position, one might examine the Cooper Companies BCG Matrix.
Who Founded Cooper Companies?
The Cooper Companies' journey began in 1958 with the establishment of Cooper Laboratories by Parker Montgomery, a Harvard-educated attorney. While precise initial equity distributions are not publicly detailed, Montgomery's vision was instrumental in shaping the company's early trajectory. The company initially focused on oral and skin care products before transitioning into the medical device sector.
Founder's Vision
Parker Montgomery, a Harvard-educated attorney, founded Cooper Laboratories in 1958. His entrepreneurial drive set the initial course for the company's development.
Early Focus
The company's initial operations centered on oral and skin care products. This early focus laid the groundwork for its future diversification.
Company Evolution
Over time, the company underwent several name changes, reflecting its evolving business. These changes included Cooper Tinsley Laboratories Inc. in 1961 and Cooper Laboratories Inc. in 1967.
Entry into Contact Lenses
A pivotal moment was the company's 1972 acquisition of GlobalVision, a British contact lens manufacturer. This marked a significant strategic shift into the medical device industry.
Strategic Acquisitions
Further expansion occurred with the 1983 acquisition of UCO Optics. This company had ties to Dr. Stanley Gordon, a pioneer in soft contact lens development.
Ownership Details
Specifics regarding early ownership stakes or founder agreements are not extensively detailed in public records. The company's growth was driven by strategic acquisitions and evolving business lines.
The company's strategic direction and growth were significantly influenced by key acquisitions, particularly its entry into the contact lens market in 1972 with the purchase of GlobalVision. This move was followed by the 1983 acquisition of UCO Optics, a company associated with Dr. Stanley Gordon, who was recognized for his contributions to soft contact lens technology. These early strategic decisions were crucial in shaping the company's core business areas, though detailed information on early investor stakes or internal equity arrangements remains limited in public disclosures. Understanding the Growth Strategy of Cooper Companies provides context for these foundational ownership and development phases.
Cooper Companies SWOT Analysis
- Complete SWOT Breakdown
- Fully Customizable
- Editable in Excel & Word
- Professional Formatting
- Investor-Ready Format
How Has Cooper Companies’s Ownership Changed Over Time?
The Cooper Companies transitioned to a publicly traded entity with its initial public offering on January 21, 1983. Since then, its ownership landscape has undergone significant transformations, reflecting changes in its major shareholding patterns. As a company listed on Nasdaq under the ticker symbol 'COO' since September 26, 2023, its ownership is predominantly held by institutional investors, mutual funds, and index funds.
| Ownership Type | Description | Impact on Ownership Structure |
|---|---|---|
| Public Offering (IPO) | Initial sale of company stock to the public. | Marked the beginning of widespread ownership by individual and institutional investors. |
| Institutional Investors | Entities like mutual funds, pension funds, and hedge funds. | Hold a substantial portion of shares, influencing company strategy through their investment decisions. |
| Mutual Funds and Index Funds | Pooled investment vehicles that track market indices or specific sectors. | Contribute to broad-based ownership and provide liquidity for the stock. |
As of July 3, 2025, The Cooper Companies commanded a market capitalization of approximately $14.62 billion. The company's financial performance, with trailing 12-month revenue of $3.99 billion as of April 30, 2025, and $3.90 billion in fiscal year 2024, indicates a trajectory of consistent growth. Detailed insights into its ownership structure and financial health are available through its 2024 Annual Report on Form 10-K, filed on December 6, 2024, and the 2025 Proxy Statement, released on February 19, 2025. These filings, alongside other Securities and Exchange Commission disclosures, are crucial for understanding the distribution of Cooper Companies stock ownership among its various shareholders.
Understanding Cooper Companies Ownership
The Cooper Companies' ownership is largely dictated by its status as a publicly traded entity. Institutional investors play a significant role in shaping its shareholder base.
- The company has been publicly traded since January 21, 1983.
- Its stock is listed on Nasdaq under the ticker symbol 'COO'.
- Institutional investors, mutual funds, and index funds are major holders of Cooper Companies stock.
- Understanding Target Market of Cooper Companies can provide context for its investor base.
Cooper Companies PESTLE Analysis
- Covers All 6 PESTLE Categories
- No Research Needed – Save Hours of Work
- Built by Experts, Trusted by Consultants
- Instant Download, Ready to Use
- 100% Editable, Fully Customizable
Who Sits on Cooper Companies’s Board?
The Cooper Companies' governance is overseen by its Board of Directors, with seven directors elected at the 2025 Annual Meeting of Stockholders. These directors serve one-year terms, with their tenure extending to the 2026 annual meeting. Albert G. White III holds the position of President and CEO, guiding the company's strategic direction.
| Director Name | Key Role/Affiliation | Term Expiration |
|---|---|---|
| Albert G. White III | President and CEO | 2026 |
| Ms. Sheffield | President of CooperSurgical | 2026 |
| Mr. Petersmeyer | Consultant, Pharmaceutical and Medical Device Industries | 2026 |
As a publicly traded company, Cooper Companies operates under a one-share-one-vote system for its common stock, a fundamental aspect of its Cooper Companies ownership structure. The company's proxy statements, such as the 2025 Proxy Statement, offer comprehensive details on board composition, executive compensation, and other vital governance elements. The board comprises individuals with diverse backgrounds, including those representing significant Cooper Companies shareholders and possessing substantial industry expertise. The absence of recent publicized proxy battles suggests a stable governance framework for Cooper Companies investor relations.
Understanding Cooper Companies Stock Ownership
The Cooper Companies stock ownership is primarily held by institutional investors and individual shareholders. Understanding who owns Cooper Companies is key to grasping its market dynamics and strategic direction.
- Institutional investors typically hold a significant portion of Cooper Companies stock ownership.
- The company's leadership, including management, may also have direct Cooper Companies management ownership.
- Individual investors also contribute to the overall Cooper Companies shareholders base.
- Information on Cooper Companies major investors list is available through regulatory filings.
For a deeper dive into the company's journey, explore the Brief History of Cooper Companies.
Cooper Companies Business Model Canvas
- Complete 9-Block Business Model Canvas
- Effortlessly Communicate Your Business Strategy
- Investor-Ready BMC Format
- 100% Editable and Customizable
- Clear and Structured Layout
What Recent Changes Have Shaped Cooper Companies’s Ownership Landscape?
In recent years, The Cooper Companies has seen shifts in its market presence, including a significant move of its stock listing. These developments, alongside consistent financial growth, shape its current ownership landscape.
| Metric | Value | Period |
|---|---|---|
| Total Revenue | $3.90 billion | Fiscal Year 2024 |
| Revenue (TTM) | $3.99 billion | As of April 30, 2025 |
| Stock Exchange Transfer | NYSE to Nasdaq | Effective September 26, 2023 |
The company's strategic initiatives, such as the acquisition of Cook Medical's reproductive health business for $875 million in March 2022, underscore its commitment to expanding its product offerings and market reach. These actions are designed to attract and retain a diverse investor base, including institutional investors who often favor companies with strong growth trajectories and clear strategic direction. The upcoming third-quarter 2025 financial results, scheduled for August 27, 2025, will offer further insights into the company's performance and potential ownership trends.
Financial Performance and Growth
The company reported an 8% revenue increase in fiscal year 2024. This consistent growth is a key factor for investors assessing Cooper Companies ownership.
Strategic Market Positioning
The transfer of its stock listing to Nasdaq in 2023 signals a move to align with innovative medical device leaders. This can influence who owns Cooper Companies by attracting a different segment of investors.
Acquisition Strategy Impact
Significant acquisitions, like the $875 million deal in 2022, bolster the company's market position. This strategic growth is closely watched by Cooper Companies shareholders.
Future Outlook and Investor Relations
The company's focus on product innovation and capacity expansion, as highlighted by its leadership, suggests a continued growth strategy. This outlook is crucial for understanding Cooper Companies investor relations and potential shifts in who are the major shareholders of Cooper Companies.
Cooper Companies Porter's Five Forces Analysis
- Covers All 5 Competitive Forces in Detail
- Structured for Consultants, Students, and Founders
- 100% Editable in Microsoft Word & Excel
- Instant Digital Download – Use Immediately
- Compatible with Mac & PC – Fully Unlocked
- What is Brief History of Cooper Companies Company?
- What is Competitive Landscape of Cooper Companies Company?
- What is Growth Strategy and Future Prospects of Cooper Companies Company?
- How Does Cooper Companies Company Work?
- What is Sales and Marketing Strategy of Cooper Companies Company?
- What are Mission Vision & Core Values of Cooper Companies Company?
- What is Customer Demographics and Target Market of Cooper Companies Company?
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.